Specialized pro-resolving mediators

Vital Nutrients Introduces Next Generation Adrenal Support Solution*

Retrieved on: 
Wednesday, November 30, 2022

MIDDLETOWN, Conn., Nov. 30, 2022 /PRNewswire/ -- Vital Nutrients, a leading practitioner-founded professional nutritional supplement company dedicated to making a positive impact on the health of people and the planet, today announc­ed the launch of its latest innovative formulation, Vegan Adrenal Support+. This next generation adrenal health solution is a first-of-its-kind, vegan formula that promotes healthy stress responses by way of the adrenal axis, including support of the CBD-endocannabinoid system, without the need for hemp-derived ingredients.*

Key Points: 
  • This next generation adrenal health solution is a first-of-its-kind, vegan formula that promotes healthy stress responsesby way of the adrenal axis, including support of the CBD-endocannabinoid system, without the need for hemp-derived ingredients.
  • *
    Vegan Adrenal Support+ is formulated with research-backed, functional ingredients to target the three Rs of Adrenal Health - Recover adrenal function, Reset the neuroendocrine communication network, and Rebalance the metabolic response.
  • Vegan Adrenal Support+ is the latest vegan-friendly innovation from Vital Nutrients.
  • *
    In accordance with Vital Nutrients' commitment to clean supplements, Vegan Adrenal Support+ is free of gluten, dairy, soy, peanut, tree nut, fish and egg, and contains no artificial flavors, colors, sweeteners, coatings or binders.

Specialized Pro-Resolving Mediators (SPMs) Shown to Resolve Inflammation and Improve Infection Clearance

Retrieved on: 
Wednesday, January 13, 2021

Specialized pro-resolving mediators, or SPMs, control the inflammation resolution process, explained study co-author Dr. Andrew G. Swick, Chief Scientific Officer at Life Extension.

Key Points: 
  • Specialized pro-resolving mediators, or SPMs, control the inflammation resolution process, explained study co-author Dr. Andrew G. Swick, Chief Scientific Officer at Life Extension.
  • This is important because chronic inflammation is best managed by both limiting inflammation in the first place and promoting the resolution of that inflammation after it occurs.
  • SPMs have shown tremendous potential for treating infectious diseases and lung conditions, Dr. Shayna Sandhaus, co-author of the article, explained.
  • Administering SPMs in preclinical studies has led to infection clearance, resolution of lung inflammation, and improved survival rates.